Description
Composition: Levofloxacin 500mg (tablets). Its activity comes from a single component, Levofloxacin (fluoroquinolone antibacterial).
Levofloxacin is a fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV.
LOVOX is a prescription medicine from Aerochem Neutron's antibiotic range, for use on the prescription of a registered medical practitioner.
Features
· Contains Levofloxacin 500mg
· Levofloxacin — fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV
· Presented as tablets
· Prescription-only medicine
Conditions
· Community-acquired pneumonia and acute bacterial exacerbation of chronic bronchitis
· Acute bacterial sinusitis
· Urinary tract infections, including pyelonephritis
· Skin and soft-tissue infections
· Other indications as per the approved prescribing information
Safety
· Contraindicated in patients with known hypersensitivity to any component.
· Fluoroquinolones carry warnings for tendinitis and tendon rupture, peripheral neuropathy, CNS effects, QT prolongation, dysglycaemia and aortic aneurysm risk, and can worsen myasthenia gravis; reserve for situations where they are clearly appropriate and avoid in pregnancy and in children unless benefits outweigh risks.
· Refer to the full prescribing information for all contraindications and interactions.
Clinical Rationale: The mechanisms and labelled uses of levofloxacin described here follow the US prescribing information (DailyMed); the EMA 2018 fluoroquinolone review restricted these agents because of disabling and potentially long-lasting adverse effects, which is why use should be limited to cases where they are clearly appropriate; antibiotic choice should follow local resistance data and the WHO AWaRe antibiotic book.
References (Verified)
· DailyMed (US NLM) prescribing information – levofloxacin: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=LEVOFLOXACIN
· EMA – Quinolone and fluoroquinolone medicines referral (2018): https://www.ema.europa.eu/en/medicines/human/referrals/quinolone-fluoroquinolone-containing-medicinal-products
· WHO AWaRe (Access, Watch, Reserve) antibiotic book (2022): https://www.who.int/publications/i/item/9789240062382
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about LOVOX- 500 for professional use.